Oscar Health Inc
$ 26.54
-11.86%
06 Aug - close price
- Market Cap 9,077,955,000 USD
- Current Price $ 26.54
- High / Low $ 28.19 / 25.80
- Stock P/E N/A
- Book Value 5.57
- EPS -0.54
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA N/A %
- ROE -0.03 %
- 52 Week High 33.10
- 52 Week Low 10.69
About
Oscar Health, Inc. offers health insurance products and services to individuals, families, and businesses in the United States. The company is headquartered in New York, New York.
Analyst Target Price
$25.20
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-06 | 2026-05-06 | 2026-02-10 | 2025-11-06 | 2025-08-06 | 2025-05-07 | 2025-02-04 | 2024-11-07 | 2024-08-07 | 2024-05-07 | 2024-02-07 | 2023-11-07 |
| Reported EPS | -0.89 | 2.07 | -1.24 | -0.53 | -0.89 | 0.92 | -0.62 | -0.22 | 0.2 | 0.62 | -0.66 | -0.29 |
| Estimated EPS | 0.43 | 1.1 | -0.92 | -0.58 | -0.84 | 0.81 | -0.58 | -0.18 | 0.16 | 0.27 | -0.7 | -0.47 |
| Surprise | -1.32 | 0.97 | -0.32 | 0.05 | -0.05 | 0.11 | -0.04 | -0.04 | 0.04 | 0.35 | 0.04 | 0.18 |
| Surprise Percentage | -306.9767% | 88.1818% | -34.7826% | 8.6207% | -5.9524% | 13.5802% | -6.8966% | -22.2222% | 25% | 129.6296% | 5.7143% | 38.2979% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OSCR
2026-08-06 10:12:40
The article reports on an 8K filing by Oscar Health Inc. on August 6th. It mentions that Oscar Health Inc. (OSCR) experienced an 11.59% drop. The content is very brief, serving primarily as an announcement of the filing.
2026-08-06 10:12:40
Oscar Health (NYSE: OSCR) announced record profitability for the first half of 2026, reporting a net income of $1,040,804 thousand and an Adjusted EBITDA of $1,142,421 thousand. The company also turned around its Q2 2026 performance with a net income of $361,808 thousand, driven by improved medical loss ratio and SG&A expense ratio. Consequently, Oscar Health raised its full-year 2026 guidance for earnings from operations to $500–$700 million, while maintaining total revenue guidance.
2026-08-01 00:06:00
This article provides an AI-driven analysis for Oscar Health Inc. Class A (NASDAQ: OSCR), highlighting positive near-term sentiment within a long-term strength context. It details institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and resistance levels. The analysis suggests compelling upside potential due to the absence of clear resistance above the current price.
2026-07-20 13:20:00
This article analyzes Oscar Health Inc. Class A (NASDAQ: OSCR) using AI models to generate trading strategies and multi-timeframe signal analysis. It highlights weak near-term sentiment but strong long-term potential, providing specific entry zones, targets, and stop losses for position trading, momentum breakout, and risk hedging strategies. The analysis also details support and resistance levels across different time horizons.
2026-07-20 13:20:00
This article analyzes Oscar Health Inc. Class A (NASDAQ: OSCR) using AI models, identifying weak near-term sentiment but strong long-term potential. It provides three distinct trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal strengths and resistance/support levels for informed trading decisions.
2026-07-13 21:20:00
This article provides a brief notification regarding the filing of a Form 4 for Oscar Health Inc. on July 13. It includes the company's stock symbol (OSCR) and its positive price performance, specifically a 1.72% increase. The content indicates that the information is primarily a regulatory announcement disseminated by Investing.com.
